A pilot study of equal doses of 10% IGIV given intravenously or subcutaneously

被引：40

作者：

Desai, Shilpa H. ^{[1
]}

Chouksey, Akhil ^{[2
]}

Poll, John ^{[2
]}

Berger, Melvin ^{[2
]}

机构：

[1] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA

[2] Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2009年 / 124卷 / 04期

关键词：

IMMUNOGLOBULIN REPLACEMENT THERAPY; PRIMARY IMMUNODEFICIENCY; EFFICACY; SAFETY;

D O I：

10.1016/j.jaci.2009.07.051

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：854 / 856

页数：3

共 8 条

[1]

Aebersold P, 2005, INTRAVENOUS IMMUNOGL

[2]

[Anonymous], 2008, GUID IND SAF EFF PHA

[3] Subcutaneous immunoglobulin replacement in primary immunodeficiencies [J].

Berger, M .

CLINICAL IMMUNOLOGY, 2004, 112 (01) :1-7

[4] Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency [J].

Berger, Melvin .

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2008, 28 (02) :413-+

[5] The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy [J].

Chapel, HM ;

Spickett, GP ;

Ericson, D ;

Engl, W ;

Eibl, MM ;

Bjorkander, J .

JOURNAL OF CLINICAL IMMUNOLOGY, 2000, 20 (02) :94-100

[6] Role of dentist in tobacco cessation intervention [J].

Choudhury, A ;

Khan, MH ;

Rahman, S ;

Khatun, F ;

Luna, AK ;

Jalal, Z ;

Alam, T .

ORAL ONCOLOGY, 2005, 1 (01) :120-120

[7]

*EMEA CPMP, 2002, CPMPBPWG28300 EMEA

[8] Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases [J].

Ochs, Hans D. ;

Gupta, Sudhir ;

Kiessling, Peter ;

Nicolay, Uwe ;

Berger, Melvin .

JOURNAL OF CLINICAL IMMUNOLOGY, 2006, 26 (03) :265-273

← 1 →